Weight Loss Drug Stocks: Biotech Breakthrough or Market Bubble?

<p><strong>The FDA&#39;s approval of a higher-dose Wegovy marks Novo Nordisk&#39;s aggressive push to reclaim market share in the exploding weight loss drug sector. Pharmaceutical investors are watching closely as competition intensifies in what could become a trillion-dollar market.</strong></p><p><strong>Today&#39;s Stocks &amp; Topics: Berkshire Hathaway Inc. (BRK.B), Market Wrap, Snap Inc. (SNAP), Caterpillar Inc. (CAT), Weight Loss Drug Stocks: Biotech Breakthrough or Market Bubble?, CDW Corporation (CDW), Petrochemical Companies, Lumen Technologies, Inc. (LUMN), Mortgage Rates, Mueller Industries, Inc. (MLI), Fertilizer Market.</strong></p><br /><br …